Document Detail

The potential of tetrandrine as a protective agent for ischemic stroke.
MedLine Citation:
PMID:  21926947     Owner:  NLM     Status:  In-Data-Review    
Stroke is one of the leading causes of mortality, with a high incidence of severe morbidity in survivors. The treatment to minimize tissue injury after stroke is still unsatisfactory and it is mandatory to develop effective treatment strategies for stroke. The pathophysiology of ischemic stroke is complex and involves many processes including energy failure, loss of ion homeostasis, increased intracellular calcium level, platelet aggregation, production of reactive oxygen species, disruption of blood brain barrier, and inflammation and leukocyte infiltration, etc. Tetrandrine, a bisbenzylisoquinoline alkaloid, has many pharmacologic effects including anti-inflammatory and cytoprotective effects. In addition, tetrandrine has been found to protect the liver, heart, small bowel and brain from ischemia/reperfusion injury. It is a calcium channel blocker, and can inhibit lipid peroxidation, reduce generation of reactive oxygen species, suppress the production of cytokines and inflammatory mediators, inhibit neutrophil recruitment and platelet aggregation, which are all devastating factors during ischemia/reperfusion injury of the brain. Because tetrandrine can counteract these important pathophysiological processes of ischemic stroke, it has the potential to be a protective agent for ischemic stroke.
Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Related Documents :
8928087 - Platelet functions and haemostasis parameters in pigs: absence of side effects of a pro...
3017497 - Prostaglandin d2 interacts at thromboxane receptor-sites on guinea-pig platelets.
2907537 - Studies in the guinea-pig with ici 185,282: a thromboxane a2 receptor antagonist.
8582087 - Mechanisms of increased airway microvascular permeability: role in airway inflammation ...
11046447 - Nonlinear poisson-boltzmann theory of a wigner-seitz model for swollen clays
15177477 - An aminomethylpyrimidine dpp-iv inhibitor with improved properties.
Publication Detail:
Type:  Journal Article     Date:  2011-09-16
Journal Detail:
Title:  Molecules (Basel, Switzerland)     Volume:  16     ISSN:  1420-3049     ISO Abbreviation:  Molecules     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100964009     Medline TA:  Molecules     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  8020-32     Citation Subset:  IM    
Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, New Taipei 220, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exploiting the nucleotide substrate specificity of repair DNA polymerases to develop novel anticance...
Next Document:  Synthesis and NMR-Study of the 2,3,4,5-Tetraethylsilole Dianion [SiC4Et4]2-•2[Li]+.